BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36613208)

  • 21. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
    Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
    Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
    Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
    Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved risk of malignancy index in diagnosis of adnexal mass.
    Wang LM; Song H; Song X; Zhou XB
    Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
    Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of malignancy index in preoperative evaluation of pelvic masses.
    Ashrafgangooei T; Rezaeezadeh M
    Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-Stage Ovarian Malignancy Score versus Risk of Malignancy Indices: Accuracy and Clinical Utility for Preoperative Diagnosis of Women with Adnexal Masses.
    Phinyo P; Patumanond J; Saenrungmuaeng P; Chirdchim W; Pipanmekaporn T; Tantraworasin A; Tongsong T; Tantipalakorn C
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33339091
    [No Abstract]   [Full Text] [Related]  

  • 29. Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery?
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2013 May; 41(5):570-81. PubMed ID: 22915541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study.
    Stukan M; Badocha M; Ratajczak K
    BMC Cancer; 2019 Jun; 19(1):564. PubMed ID: 31185938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
    Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
    Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
    Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
    Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
    Poonyakanok V; Tanmahasamut P; Jaishuen A
    J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
    Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the risk of malignancy index and self-constructed logistic regression models in preoperative evaluation of adnexal masses.
    Yörük P; Dündar O; Yildizhan B; Tütüncü L; Pekin T
    J Ultrasound Med; 2008 Oct; 27(10):1469-77. PubMed ID: 18809957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of adnexal masses: correlation between clinical, ultrasound and histopathological findings.
    Dotlić J; Terzić M; Likić I; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Oct; 68(10):861-6. PubMed ID: 22165752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses.
    Andersen ES; Knudsen A; Rix P; Johansen B
    Gynecol Oncol; 2003 Jul; 90(1):109-12. PubMed ID: 12821350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.